KR20210111711A

KR20210111711A - Kras 돌연변이 및 활성화된 ron이 존재하는 암의 예방 또는 치료용 약학 조성물

Kras 돌연변이 및 활성화된 ron이 존재하는 암의 예방 또는 치료용 약학 조성물 Download PDF

Info

Publication number: KR20210111711A
Authority: KR; South Korea
Prior art keywords: oxo; oxy; fluorophenyl; phenyl; carboxamide
Prior art date: 2020-03-03
Legal status : Pending

Application number

KR1020210028396A

Other languages

English (en)

Korean (ko)

Inventor

신재식

고영옥

이민기

김용석

최순진

임나정

김민화

이준형

Original Assignee

웰마커바이오 주식회사

Priority date

2020-03-03

Filing date

2021-03-03

Publication date

2021-09-13

2021-03-03 Application filed by 웰마커바이오 주식회사 filed Critical 웰마커바이오 주식회사

2021-09-13 Publication of KR20210111711A publication Critical patent/KR20210111711A/ko

Status Pending legal-status Critical Current

Links

206010028980 Neoplasm Diseases 0.000 title claims abstract description 48
206010069755 K-ras gene mutation Diseases 0.000 title claims abstract description 32
201000011510 cancer Diseases 0.000 title claims abstract description 27
239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 26
102100030708 GTPase KRas Human genes 0.000 claims abstract description 23
101000584612 Homo sapiens GTPase KRas Proteins 0.000 claims abstract description 23
239000002246 antineoplastic agent Substances 0.000 claims abstract description 10
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 5
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract description 5
150000001875 compounds Chemical class 0.000 claims description 115
125000000217 alkyl group Chemical group 0.000 claims description 98
108700003853 RON Proteins 0.000 claims description 73
229910052736 halogen Inorganic materials 0.000 claims description 68
150000002367 halogens Chemical class 0.000 claims description 66
125000003545 alkoxy group Chemical group 0.000 claims description 59
125000000592 heterocycloalkyl group Chemical group 0.000 claims description 51
-1 nitro, amino Chemical group 0.000 claims description 40
238000000034 method Methods 0.000 claims description 37
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 34
125000000623 heterocyclic group Chemical group 0.000 claims description 32
229910052739 hydrogen Inorganic materials 0.000 claims description 31
239000001257 hydrogen Substances 0.000 claims description 31
125000000753 cycloalkyl group Chemical group 0.000 claims description 29
125000001072 heteroaryl group Chemical group 0.000 claims description 28
125000005842 heteroatom Chemical group 0.000 claims description 27
206010009944 Colon cancer Diseases 0.000 claims description 26
125000001424 substituent group Chemical group 0.000 claims description 26
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 22
150000001413 amino acids Chemical group 0.000 claims description 20
125000003118 aryl group Chemical group 0.000 claims description 18
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 18
239000004471 Glycine Substances 0.000 claims description 17
230000035772 mutation Effects 0.000 claims description 17
229910052760 oxygen Inorganic materials 0.000 claims description 16
229910052717 sulfur Inorganic materials 0.000 claims description 16
238000011282 treatment Methods 0.000 claims description 16
235000001014 amino acid Nutrition 0.000 claims description 14
229910052757 nitrogen Inorganic materials 0.000 claims description 14
125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 13
125000000539 amino acid group Chemical group 0.000 claims description 12
150000003839 salts Chemical class 0.000 claims description 11
125000003806 alkyl carbonyl amino group Chemical group 0.000 claims description 10
125000004093 cyano group Chemical group *C#N 0.000 claims description 10
125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 10
125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 9
239000004480 active ingredient Substances 0.000 claims description 9
125000004433 nitrogen atom Chemical group N* 0.000 claims description 9
125000004043 oxo group Chemical group O=* 0.000 claims description 9
125000003282 alkyl amino group Chemical group 0.000 claims description 8
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 8
125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 7
125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 7
229910052799 carbon Inorganic materials 0.000 claims description 7
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
208000029742 colonic neoplasm Diseases 0.000 claims description 6
108700024394 Exon Proteins 0.000 claims description 5
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 5
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 5
235000003704 aspartic acid Nutrition 0.000 claims description 5
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 5
230000002265 prevention Effects 0.000 claims description 5
229940124597 therapeutic agent Drugs 0.000 claims description 5
239000004474 valine Substances 0.000 claims description 5
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
PZAZFTZOVUYEET-UHFFFAOYSA-N N-[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C=2N=CN(C2)C)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 PZAZFTZOVUYEET-UHFFFAOYSA-N 0.000 claims description 4
BIXSOPZNVOXSPX-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 BIXSOPZNVOXSPX-UHFFFAOYSA-N 0.000 claims description 4
AUAUKDIIIINUBS-UHFFFAOYSA-N N-[4-[7-[3-(3-cyanoazetidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound C(#N)C1CN(C1)CCCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC AUAUKDIIIINUBS-UHFFFAOYSA-N 0.000 claims description 4
206010061902 Pancreatic neoplasm Diseases 0.000 claims description 4
125000003342 alkenyl group Chemical group 0.000 claims description 4
125000001188 haloalkyl group Chemical group 0.000 claims description 4
208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 4
201000002528 pancreatic cancer Diseases 0.000 claims description 4
208000008443 pancreatic carcinoma Diseases 0.000 claims description 4
KFCOLWPNPQLLPP-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-oxo-1-phenylpyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CNCCOC)C=C3)C=C2)C(=O)N(C=C1)C1=CC=CC=C1 KFCOLWPNPQLLPP-UHFFFAOYSA-N 0.000 claims description 3
QXORIRDRABRRSI-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[(4-methylpiperazin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-oxo-1-phenylpyridine-3-carboxamide Chemical compound CCOc1ccn(-c2ccccc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc3cc(sc23)-c2ccc(CN3CCN(C)CC3)cn2)c(F)c1 QXORIRDRABRRSI-UHFFFAOYSA-N 0.000 claims description 3
206010006187 Breast cancer Diseases 0.000 claims description 3
208000026310 Breast neoplasm Diseases 0.000 claims description 3
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 2
LVQQAXADCOEAFY-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-(morpholin-4-ylmethyl)pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CN4CCOCC4)C=C3)C=C2)C(=O)N(C=C1)C1=CC=C(F)C=C1 LVQQAXADCOEAFY-UHFFFAOYSA-N 0.000 claims description 2
239000004475 Arginine Substances 0.000 claims description 2
125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 2
125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 2
208000008839 Kidney Neoplasms Diseases 0.000 claims description 2
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
206010033128 Ovarian cancer Diseases 0.000 claims description 2
206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
206010060862 Prostate cancer Diseases 0.000 claims description 2
208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
206010038389 Renal cancer Diseases 0.000 claims description 2
208000000453 Skin Neoplasms Diseases 0.000 claims description 2
208000005718 Stomach Neoplasms Diseases 0.000 claims description 2
208000024770 Thyroid neoplasm Diseases 0.000 claims description 2
208000002495 Uterine Neoplasms Diseases 0.000 claims description 2
125000000304 alkynyl group Chemical group 0.000 claims description 2
238000011394 anticancer treatment Methods 0.000 claims description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
235000018417 cysteine Nutrition 0.000 claims description 2
206010017758 gastric cancer Diseases 0.000 claims description 2
201000010536 head and neck cancer Diseases 0.000 claims description 2
208000014829 head and neck neoplasm Diseases 0.000 claims description 2
235000014304 histidine Nutrition 0.000 claims description 2
201000010982 kidney cancer Diseases 0.000 claims description 2
201000007270 liver cancer Diseases 0.000 claims description 2
208000014018 liver neoplasm Diseases 0.000 claims description 2
201000005202 lung cancer Diseases 0.000 claims description 2
208000020816 lung neoplasm Diseases 0.000 claims description 2
125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims description 2
201000000849 skin cancer Diseases 0.000 claims description 2
201000011549 stomach cancer Diseases 0.000 claims description 2
201000002510 thyroid cancer Diseases 0.000 claims description 2
206010046766 uterine cancer Diseases 0.000 claims description 2
235000014393 valine Nutrition 0.000 claims description 2
230000006907 apoptotic process Effects 0.000 abstract description 20
230000001939 inductive effect Effects 0.000 abstract description 12
230000001747 exhibiting effect Effects 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 63
239000013641 positive control Substances 0.000 description 37
208000001333 Colorectal Neoplasms Diseases 0.000 description 20
230000014509 gene expression Effects 0.000 description 18
239000000203 mixture Substances 0.000 description 18
150000002431 hydrogen Chemical class 0.000 description 15
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 15
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 13
125000004432 carbon atom Chemical group C* 0.000 description 11
239000003814 drug Substances 0.000 description 11
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 10
238000004458 analytical method Methods 0.000 description 10
230000000694 effects Effects 0.000 description 9
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
108090000623 proteins and genes Proteins 0.000 description 9
108060000903 Beta-catenin Proteins 0.000 description 8
108020004414 DNA Proteins 0.000 description 8
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
201000010099 disease Diseases 0.000 description 8
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
238000010172 mouse model Methods 0.000 description 8
102200006532 rs112445441 Human genes 0.000 description 8
102200006531 rs121913529 Human genes 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
230000004614 tumor growth Effects 0.000 description 8
102000015735 Beta-catenin Human genes 0.000 description 7
102000003952 Caspase 3 Human genes 0.000 description 7
108090000397 Caspase 3 Proteins 0.000 description 7
102000006311 Cyclin D1 Human genes 0.000 description 7
108010058546 Cyclin D1 Proteins 0.000 description 7
229910052794 bromium Inorganic materials 0.000 description 7
229910052801 chlorine Inorganic materials 0.000 description 7
229940079593 drug Drugs 0.000 description 7
229910052731 fluorine Inorganic materials 0.000 description 7
229910052740 iodine Inorganic materials 0.000 description 7
241000282414 Homo sapiens Species 0.000 description 6
241000699670 Mus sp. Species 0.000 description 6
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
230000008859 change Effects 0.000 description 6
239000002299 complementary DNA Substances 0.000 description 6
230000002401 inhibitory effect Effects 0.000 description 6
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
235000018102 proteins Nutrition 0.000 description 6
102000004169 proteins and genes Human genes 0.000 description 6
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 5
239000000654 additive Substances 0.000 description 5
SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 5
238000010171 animal model Methods 0.000 description 5
125000004429 atom Chemical group 0.000 description 5
230000003247 decreasing effect Effects 0.000 description 5
238000009472 formulation Methods 0.000 description 5
239000003112 inhibitor Substances 0.000 description 5
230000005764 inhibitory process Effects 0.000 description 5
238000010186 staining Methods 0.000 description 5
239000000126 substance Substances 0.000 description 5
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 4
230000000692 anti-sense effect Effects 0.000 description 4
125000002393 azetidinyl group Chemical group 0.000 description 4
125000001153 fluoro group Chemical group F* 0.000 description 4
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 4
239000002773 nucleotide Substances 0.000 description 4
125000003729 nucleotide group Chemical group 0.000 description 4
239000000546 pharmaceutical excipient Substances 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
230000008685 targeting Effects 0.000 description 4
DBDCNCCRPKTRSD-UHFFFAOYSA-N thieno[3,2-b]pyridine Chemical compound C1=CC=C2SC=CC2=N1 DBDCNCCRPKTRSD-UHFFFAOYSA-N 0.000 description 4
229940125670 thienopyridine Drugs 0.000 description 4
239000002175 thienopyridine Substances 0.000 description 4
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
230000009471 action Effects 0.000 description 3
125000002947 alkylene group Chemical group 0.000 description 3
230000037396 body weight Effects 0.000 description 3
230000030833 cell death Effects 0.000 description 3
229940125904 compound 1 Drugs 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
238000001647 drug administration Methods 0.000 description 3
239000003995 emulsifying agent Substances 0.000 description 3
239000000839 emulsion Substances 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
125000002883 imidazolyl group Chemical group 0.000 description 3
230000000984 immunochemical effect Effects 0.000 description 3
239000008101 lactose Substances 0.000 description 3
235000019359 magnesium stearate Nutrition 0.000 description 3
125000002971 oxazolyl group Chemical group 0.000 description 3
UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
125000004193 piperazinyl group Chemical group 0.000 description 3
125000003386 piperidinyl group Chemical group 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
125000003226 pyrazolyl group Chemical group 0.000 description 3
125000004076 pyridyl group Chemical group 0.000 description 3
125000000719 pyrrolidinyl group Chemical group 0.000 description 3
230000009257 reactivity Effects 0.000 description 3
230000001603 reducing effect Effects 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
239000000375 suspending agent Substances 0.000 description 3
238000001308 synthesis method Methods 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
239000000454 talc Substances 0.000 description 3
229910052623 talc Inorganic materials 0.000 description 3
235000012222 talc Nutrition 0.000 description 3
238000001262 western blot Methods 0.000 description 3
CIISBYKBBMFLEZ-UHFFFAOYSA-N 1,2-oxazolidine Chemical compound C1CNOC1 CIISBYKBBMFLEZ-UHFFFAOYSA-N 0.000 description 2
CZSRXHJVZUBEGW-UHFFFAOYSA-N 1,2-thiazolidine Chemical compound C1CNSC1 CZSRXHJVZUBEGW-UHFFFAOYSA-N 0.000 description 2
OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 2
AMFYRKOUWBAGHV-UHFFFAOYSA-N 1h-pyrazolo[4,3-b]pyridine Chemical compound C1=CN=C2C=NNC2=C1 AMFYRKOUWBAGHV-UHFFFAOYSA-N 0.000 description 2
XWIYUCRMWCHYJR-UHFFFAOYSA-N 1h-pyrrolo[3,2-b]pyridine Chemical compound C1=CC=C2NC=CC2=N1 XWIYUCRMWCHYJR-UHFFFAOYSA-N 0.000 description 2
GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 description 2
KDOPAZIWBAHVJB-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]pyrimidine Chemical compound C1=NC=C2NC=CC2=N1 KDOPAZIWBAHVJB-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
238000011729 BALB/c nude mouse Methods 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 2
108010092160 Dactinomycin Proteins 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
102100032813 Hepatocyte growth factor-like protein Human genes 0.000 description 2
101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 description 2
WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 2
GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 description 2
231100000070 MTS assay Toxicity 0.000 description 2
238000000719 MTS assay Methods 0.000 description 2
206010027476 Metastases Diseases 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
101710135898 Myc proto-oncogene protein Proteins 0.000 description 2
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 2
241000286209 Phasianidae Species 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
235000021355 Stearic acid Nutrition 0.000 description 2
FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
101710150448 Transcriptional regulator Myc Proteins 0.000 description 2
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 2
208000009956 adenocarcinoma Diseases 0.000 description 2
230000001093 anti-cancer Effects 0.000 description 2
230000001028 anti-proliverative effect Effects 0.000 description 2
229940041181 antineoplastic drug Drugs 0.000 description 2
VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 2
ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
239000002775 capsule Substances 0.000 description 2
229960004562 carboplatin Drugs 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
OGEBRHQLRGFBNV-RZDIXWSQSA-N chembl2036808 Chemical compound C12=NC(NCCCC)=NC=C2C(C=2C=CC(F)=CC=2)=NN1C[C@H]1CC[C@H](N)CC1 OGEBRHQLRGFBNV-RZDIXWSQSA-N 0.000 description 2
231100000135 cytotoxicity Toxicity 0.000 description 2
230000003013 cytotoxicity Effects 0.000 description 2
229960000640 dactinomycin Drugs 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
YRTMEEURRDTMST-UHFFFAOYSA-N diazetidine Chemical compound C1CNN1 YRTMEEURRDTMST-UHFFFAOYSA-N 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
235000003599 food sweetener Nutrition 0.000 description 2
YRTCKZIKGWZNCU-UHFFFAOYSA-N furo[3,2-b]pyridine Chemical compound C1=CC=C2OC=CC2=N1 YRTCKZIKGWZNCU-UHFFFAOYSA-N 0.000 description 2
125000002541 furyl group Chemical group 0.000 description 2
125000005843 halogen group Chemical group 0.000 description 2
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
238000003125 immunofluorescent labeling Methods 0.000 description 2
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 2
125000001786 isothiazolyl group Chemical group 0.000 description 2
239000007951 isotonicity adjuster Substances 0.000 description 2
125000000842 isoxazolyl group Chemical group 0.000 description 2
239000003446 ligand Substances 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
239000003550 marker Substances 0.000 description 2
230000009401 metastasis Effects 0.000 description 2
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
239000013642 negative control Substances 0.000 description 2
125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
125000006574 non-aromatic ring group Chemical group 0.000 description 2
208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
238000007911 parenteral administration Methods 0.000 description 2
230000026731 phosphorylation Effects 0.000 description 2
238000006366 phosphorylation reaction Methods 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
239000006187 pill Substances 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
239000000843 powder Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 description 2
125000000168 pyrrolyl group Chemical group 0.000 description 2
102000016914 ras Proteins Human genes 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
102200006539 rs121913529 Human genes 0.000 description 2
239000000523 sample Substances 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000008117 stearic acid Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 2
239000000829 suppository Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
239000003765 sweetening agent Substances 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
239000003826 tablet Substances 0.000 description 2
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
125000000335 thiazolyl group Chemical group 0.000 description 2
BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 2
238000002054 transplantation Methods 0.000 description 2
208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
MWWSFMDVAYGXBV-MYPASOLCSA-N (7r,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride Chemical compound Cl.O([C@@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-MYPASOLCSA-N 0.000 description 1
125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 description 1
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 1
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
SHTFHGKFUJAPEF-UHFFFAOYSA-N 1-(4-chlorophenyl)-4-ethoxy-N-[3-fluoro-4-[2-[5-(morpholin-4-ylmethyl)pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-oxopyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CN4CCOCC4)C=C3)C=C2)C(=O)N(C=C1)C1=CC=C(Cl)C=C1 SHTFHGKFUJAPEF-UHFFFAOYSA-N 0.000 description 1
ZONFFSSSBCJMPG-UHFFFAOYSA-N 1-(4-chlorophenyl)-4-ethoxy-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-oxopyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CNCCOC)C=C3)C=C2)C(=O)N(C=C1)C1=CC=C(Cl)C=C1 ZONFFSSSBCJMPG-UHFFFAOYSA-N 0.000 description 1
AVQMZXNIWUWSRB-UHFFFAOYSA-N 1-(4-chlorophenyl)-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-4-methoxy-2-oxopyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=C(F)C=C(NC(=O)C4=C(OC)C=CN(C4=O)C4=CC=C(Cl)C=C4)C=C3)=C2S1 AVQMZXNIWUWSRB-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
RVWYHQUKEJBAIS-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-(morpholin-4-ylmethyl)pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide hydrochloride Chemical compound Cl.CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc3cc(sc23)-c2ccc(CN3CCOCC3)cn2)c(F)c1 RVWYHQUKEJBAIS-UHFFFAOYSA-N 0.000 description 1
QFVBULFWMRQZKW-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-(morpholin-4-ylmethyl)pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-oxo-1-phenylpyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CN4CCOCC4)C=C3)C=C2)C(=O)N(C=C1)C1=CC=CC=C1 QFVBULFWMRQZKW-UHFFFAOYSA-N 0.000 description 1
LKFIRSDCHCIKSS-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(3-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CNCCOC)C=C3)C=C2)C(=O)N(C=C1)C1=CC(F)=CC=C1 LKFIRSDCHCIKSS-UHFFFAOYSA-N 0.000 description 1
CWEYLJRAVZNSGW-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(3-methoxyphenyl)-2-oxopyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CNCCOC)C=C3)C=C2)C(=O)N(C=C1)C1=CC(OC)=CC=C1 CWEYLJRAVZNSGW-UHFFFAOYSA-N 0.000 description 1
LYKVLRSTJMGUBV-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CNCCOC)C=C3)C=C2)C(=O)N(C=C1)C1=CC=C(F)C=C1 LYKVLRSTJMGUBV-UHFFFAOYSA-N 0.000 description 1
VANZRUICRKHKKD-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-methoxyphenyl)-2-oxopyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CNCCOC)C=C3)C=C2)C(=O)N(C=C1)C1=CC=C(OC)C=C1 VANZRUICRKHKKD-UHFFFAOYSA-N 0.000 description 1
IFVPBWODUQOFBX-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-oxo-1-[4-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound CCOC1=C(C(=O)NC2=CC(F)=C(OC3=C4SC(=CC4=NC=C3)C3=NC=C(CNCCOC)C=C3)C=C2)C(=O)N(C=C1)C1=CC=C(C=C1)C(F)(F)F IFVPBWODUQOFBX-UHFFFAOYSA-N 0.000 description 1
ZCBMOVPDYVSXDH-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-oxo-1-phenylpyridine-3-carboxamide hydrochloride Chemical compound Cl.C(C)OC1=C(C(N(C=C1)C1=CC=CC=C1)=O)C(=O)NC1=CC(=C(C=C1)OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CNCCOC)F ZCBMOVPDYVSXDH-UHFFFAOYSA-N 0.000 description 1
KGRZLPCJGDFXPZ-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[(4-methylpiperazin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound C(C)OC1=C(C(N(C=C1)C1=CC=C(C=C1)F)=O)C(=O)NC1=CC(=C(C=C1)OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CN1CCN(CC1)C)F KGRZLPCJGDFXPZ-UHFFFAOYSA-N 0.000 description 1
AWRPRJPUFUSQRV-UHFFFAOYSA-N 4-ethoxy-N-[3-fluoro-4-[2-[5-[[2-methoxyethyl(methyl)amino]methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound C(C)OC1=C(C(N(C=C1)C1=CC=C(C=C1)F)=O)C(=O)NC1=CC(=C(C=C1)OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CN(C)CCOC)F AWRPRJPUFUSQRV-UHFFFAOYSA-N 0.000 description 1
125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
MJRZEAAKUOQTAX-UHFFFAOYSA-N 5-(4-fluorophenyl)-7-[2-[3-fluoro-4-[7-(3-piperidin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]acetyl]-2,3-dihydrofuro[3,2-c]pyridin-6-one Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=CC=C12)OCCCN1CCCCC1)CC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 MJRZEAAKUOQTAX-UHFFFAOYSA-N 0.000 description 1
ANANALLCCSZKCV-UHFFFAOYSA-N 5-(4-fluorophenyl)-N-[3-fluoro-4-(2-pyridin-2-ylthieno[3,2-b]pyridin-7-yl)oxyphenyl]-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=CC=C2)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 ANANALLCCSZKCV-UHFFFAOYSA-N 0.000 description 1
NIJRJRYVFDPPEW-UHFFFAOYSA-N 5-(4-fluorophenyl)-N-[3-fluoro-4-[2-[5-(piperidin-1-ylmethyl)pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CCCCC2)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 NIJRJRYVFDPPEW-UHFFFAOYSA-N 0.000 description 1
AIXQEUDSQGWEAN-UHFFFAOYSA-N 5-(4-fluorophenyl)-N-[3-fluoro-4-[2-[5-(pyrrolidin-1-ylmethyl)pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CCCC2)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 AIXQEUDSQGWEAN-UHFFFAOYSA-N 0.000 description 1
UEAYLSWZZYMPKV-UHFFFAOYSA-N 5-bromo-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=C(F)C=C(NC(=O)C4=CC(Br)=CN(C4=O)C4=CC=C(F)C=C4)C=C3)=C2S1 UEAYLSWZZYMPKV-UHFFFAOYSA-N 0.000 description 1
UAQLSJWPLQGMFW-UHFFFAOYSA-N 5-chloro-N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=C(F)C=C(NC(=O)C4=CC(Cl)=CN(C4=O)C4=CC=C(F)C=C4)C=C3)=C2S1 UAQLSJWPLQGMFW-UHFFFAOYSA-N 0.000 description 1
VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
ZLAHUZNTCKHNKN-UHFFFAOYSA-N 7-[2-[3-fluoro-4-[7-[3-(4-methylpiperidin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]acetyl]-5-(4-fluorophenyl)-2,3-dihydrofuro[3,2-c]pyridin-6-one Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=CC=C12)OCCCN1CCC(CC1)C)CC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 ZLAHUZNTCKHNKN-UHFFFAOYSA-N 0.000 description 1
102000005758 Adenosylmethionine decarboxylase Human genes 0.000 description 1
108010070753 Adenosylmethionine decarboxylase Proteins 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 1
DXQIQUIQYAGRCC-CIUDSAMLSA-N Arg-Asp-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)CN=C(N)N DXQIQUIQYAGRCC-CIUDSAMLSA-N 0.000 description 1
MTANSHNQTWPZKP-KKUMJFAQSA-N Arg-Gln-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N)O MTANSHNQTWPZKP-KKUMJFAQSA-N 0.000 description 1
MZRBYBIQTIKERR-GUBZILKMSA-N Arg-Glu-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MZRBYBIQTIKERR-GUBZILKMSA-N 0.000 description 1
OHYQKYUTLIPFOX-ZPFDUUQYSA-N Arg-Glu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OHYQKYUTLIPFOX-ZPFDUUQYSA-N 0.000 description 1
UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 1
BECXEHHOZNFFFX-IHRRRGAJSA-N Arg-Ser-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BECXEHHOZNFFFX-IHRRRGAJSA-N 0.000 description 1
ULBHWNVWSCJLCO-NHCYSSNCSA-N Arg-Val-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N ULBHWNVWSCJLCO-NHCYSSNCSA-N 0.000 description 1
JGIAYNNXZKKKOW-KKUMJFAQSA-N Asn-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N JGIAYNNXZKKKOW-KKUMJFAQSA-N 0.000 description 1
FODVBOKTYKYRFJ-CIUDSAMLSA-N Asn-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N FODVBOKTYKYRFJ-CIUDSAMLSA-N 0.000 description 1
NECWUSYTYSIFNC-DLOVCJGASA-N Asp-Ala-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 NECWUSYTYSIFNC-DLOVCJGASA-N 0.000 description 1
JNNVNVRBYUJYGS-CIUDSAMLSA-N Asp-Leu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O JNNVNVRBYUJYGS-CIUDSAMLSA-N 0.000 description 1
IVPNEDNYYYFAGI-GARJFASQSA-N Asp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N IVPNEDNYYYFAGI-GARJFASQSA-N 0.000 description 1
RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
229940122361 Bisphosphonate Drugs 0.000 description 1
108010006654 Bleomycin Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
244000056139 Brassica cretica Species 0.000 description 1
235000003351 Brassica cretica Nutrition 0.000 description 1
235000003343 Brassica rupestris Nutrition 0.000 description 1
COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 1
GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
206010052358 Colorectal cancer metastatic Diseases 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
208000028399 Critical Illness Diseases 0.000 description 1
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
CUXIOFHFFXNUGG-HTFCKZLJSA-N Cys-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CS)N CUXIOFHFFXNUGG-HTFCKZLJSA-N 0.000 description 1
YQEHNIKPAOPBNH-DCAQKATOSA-N Cys-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N YQEHNIKPAOPBNH-DCAQKATOSA-N 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
239000012624 DNA alkylating agent Substances 0.000 description 1
229940123780 DNA topoisomerase I inhibitor Drugs 0.000 description 1
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000283086 Equidae Species 0.000 description 1
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 1
108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
235000016623 Fragaria vesca Nutrition 0.000 description 1
240000009088 Fragaria x ananassa Species 0.000 description 1
235000011363 Fragaria x ananassa Nutrition 0.000 description 1
101710113436 GTPase KRas Proteins 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
NNQHEEQNPQYPGL-FXQIFTODSA-N Gln-Ala-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NNQHEEQNPQYPGL-FXQIFTODSA-N 0.000 description 1
SNLOOPZHAQDMJG-CIUDSAMLSA-N Gln-Glu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SNLOOPZHAQDMJG-CIUDSAMLSA-N 0.000 description 1
LWYUQLZOIORFFJ-XKBZYTNZSA-N Glu-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O LWYUQLZOIORFFJ-XKBZYTNZSA-N 0.000 description 1
BHPQOIPBLYJNAW-NGZCFLSTSA-N Gly-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN BHPQOIPBLYJNAW-NGZCFLSTSA-N 0.000 description 1
JPVGHHQGKPQYIL-KBPBESRZSA-N Gly-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 JPVGHHQGKPQYIL-KBPBESRZSA-N 0.000 description 1
DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
102400000932 Gonadoliberin-1 Human genes 0.000 description 1
208000002250 Hematologic Neoplasms Diseases 0.000 description 1
102100024025 Heparanase Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000916173 Homo sapiens Catenin beta-1 Proteins 0.000 description 1
101500026183 Homo sapiens Gonadoliberin-1 Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 1
XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 1
QYZYJFXHXYUZMZ-UGYAYLCHSA-N Ile-Asn-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N QYZYJFXHXYUZMZ-UGYAYLCHSA-N 0.000 description 1
KIMHKBDJQQYLHU-PEFMBERDSA-N Ile-Glu-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KIMHKBDJQQYLHU-PEFMBERDSA-N 0.000 description 1
AMSYMDIIIRJRKZ-HJPIBITLSA-N Ile-His-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N AMSYMDIIIRJRKZ-HJPIBITLSA-N 0.000 description 1
OUUCIIJSBIBCHB-ZPFDUUQYSA-N Ile-Leu-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O OUUCIIJSBIBCHB-ZPFDUUQYSA-N 0.000 description 1
NZGTYCMLUGYMCV-XUXIUFHCSA-N Ile-Lys-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N NZGTYCMLUGYMCV-XUXIUFHCSA-N 0.000 description 1
GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
102000010638 Kinesin Human genes 0.000 description 1
108010063296 Kinesin Proteins 0.000 description 1
101150105104 Kras gene Proteins 0.000 description 1
SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
239000002146 L01XE16 - Crizotinib Substances 0.000 description 1
239000002176 L01XE26 - Cabozantinib Substances 0.000 description 1
AUBMZAMQCOYSIC-MNXVOIDGSA-N Leu-Ile-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O AUBMZAMQCOYSIC-MNXVOIDGSA-N 0.000 description 1
PDQDCFBVYXEFSD-SRVKXCTJSA-N Leu-Leu-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PDQDCFBVYXEFSD-SRVKXCTJSA-N 0.000 description 1
AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 1
NDORZBUHCOJQDO-GVXVVHGQSA-N Lys-Gln-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O NDORZBUHCOJQDO-GVXVVHGQSA-N 0.000 description 1
PBIPLDMFHAICIP-DCAQKATOSA-N Lys-Glu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PBIPLDMFHAICIP-DCAQKATOSA-N 0.000 description 1
PRSBSVAVOQOAMI-BJDJZHNGSA-N Lys-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN PRSBSVAVOQOAMI-BJDJZHNGSA-N 0.000 description 1
102000043136 MAP kinase family Human genes 0.000 description 1
108091054455 MAP kinase family Proteins 0.000 description 1
229940124761 MMP inhibitor Drugs 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
FXBKQTOGURNXSL-HJGDQZAQSA-N Met-Thr-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O FXBKQTOGURNXSL-HJGDQZAQSA-N 0.000 description 1
101710181812 Methionine aminopeptidase Proteins 0.000 description 1
102000029749 Microtubule Human genes 0.000 description 1
108091022875 Microtubule Proteins 0.000 description 1
UVBHKULZWFACFT-UHFFFAOYSA-N N-[2-chloro-4-[2-[5-(morpholin-4-ylmethyl)pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound ClC1=C(C=CC(=C1)OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CN1CCOCC1)NC(=O)C=1C(N(C=CC=1OCC)C1=CC=C(C=C1)F)=O UVBHKULZWFACFT-UHFFFAOYSA-N 0.000 description 1
TVJIXVOEXRTCBG-UHFFFAOYSA-N N-[2-chloro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-4-methoxy-2-oxopyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=CC(Cl)=C(NC(=O)C4=C(OC)C=CN(C4=O)C4=CC=C(F)C=C4)C=C3)=C2S1 TVJIXVOEXRTCBG-UHFFFAOYSA-N 0.000 description 1
NWVIVNOWNDSINT-UHFFFAOYSA-N N-[2-chloro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound ClC1=C(C=CC(=C1)OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CNCCOC)NC(=O)C=1C(N(C=CC=1OCC)C1=CC=C(C=C1)F)=O NWVIVNOWNDSINT-UHFFFAOYSA-N 0.000 description 1
JAOMDSFBEZLNJU-UHFFFAOYSA-N N-[3-chloro-4-[2-[5-(morpholin-4-ylmethyl)pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CN1CCOCC1)NC(=O)C=1C(N(C=CC=1OCC)C1=CC=C(C=C1)F)=O JAOMDSFBEZLNJU-UHFFFAOYSA-N 0.000 description 1
MRPKBMAVEHCXRU-UHFFFAOYSA-N N-[3-chloro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-4-methoxy-2-oxopyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=C(Cl)C=C(NC(=O)C4=C(OC)C=CN(C4=O)C4=CC=C(F)C=C4)C=C3)=C2S1 MRPKBMAVEHCXRU-UHFFFAOYSA-N 0.000 description 1
AVUUOWLZARSXOR-UHFFFAOYSA-N N-[3-fluoro-4-(6-methoxyquinolin-4-yl)oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC=C(C=C12)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 AVUUOWLZARSXOR-UHFFFAOYSA-N 0.000 description 1
SBUGUVDBEHRWEP-UHFFFAOYSA-N N-[3-fluoro-4-(7-methoxyquinolin-4-yl)oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=CC=C12)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 SBUGUVDBEHRWEP-UHFFFAOYSA-N 0.000 description 1
HBVDNFXVRYOMON-UHFFFAOYSA-N N-[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]-6-oxo-5-phenyl-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C=2N=CN(C2)C)NC(=O)C2=C1C(=CN(C2=O)C2=CC=CC=C2)CCO1 HBVDNFXVRYOMON-UHFFFAOYSA-N 0.000 description 1
MADRSBBQRVAOHP-UHFFFAOYSA-N N-[3-fluoro-4-[2-(1-methylpyrazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C=2C=NN(C2)C)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 MADRSBBQRVAOHP-UHFFFAOYSA-N 0.000 description 1
SBDCJKPFBKECEN-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=C(F)C=C(NC(=O)C4=CC=CN(C4=O)C4=CC=C(F)C=C4)C=C3)=C2S1 SBDCJKPFBKECEN-UHFFFAOYSA-N 0.000 description 1
PXZCVBQTKJNRIY-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-4-methoxy-2-oxopyridine-3-carboxamide Chemical compound FC=1C=C(C=CC=1OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CNCCOC)NC(=O)C=1C(N(C=CC=1OC)C1=CC=C(C=C1)F)=O PXZCVBQTKJNRIY-UHFFFAOYSA-N 0.000 description 1
CURGTYVNEHTWDV-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-4-methyl-2-oxopyridine-3-carboxamide Chemical compound FC=1C=C(C=CC=1OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CNCCOC)NC(=O)C=1C(N(C=CC=1C)C1=CC=C(C=C1)F)=O CURGTYVNEHTWDV-UHFFFAOYSA-N 0.000 description 1
NXUODRWFXMNITR-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-5-methyl-2-oxopyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=C(F)C=C(NC(=O)C4=CC(C)=CN(C4=O)C4=CC=C(F)C=C4)C=C3)=C2S1 NXUODRWFXMNITR-UHFFFAOYSA-N 0.000 description 1
COXXJQGTUOBHSS-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide Chemical compound FC=1C=C(C=CC=1OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CNCCOC)NC(=O)C=1C(N(C(=CC=1)C)C1=CC=C(C=C1)F)=O COXXJQGTUOBHSS-UHFFFAOYSA-N 0.000 description 1
GDQSZMFRMNXJBK-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound FC=1C=C(C=CC=1OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CNCCOC)NC(=O)C=1C(N(N=CC=1)C1=CC=C(C=C1)F)=O GDQSZMFRMNXJBK-UHFFFAOYSA-N 0.000 description 1
SJHHJUYEBYTNNE-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-(4-fluorophenyl)-5-methyl-3-oxopyridazine-4-carboxamide Chemical compound FC=1C=C(C=CC=1OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CNCCOC)NC(=O)C=1C(N(N=CC=1C)C1=CC=C(C=C1)F)=O SJHHJUYEBYTNNE-UHFFFAOYSA-N 0.000 description 1
WACIAMHZBIQEAD-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-oxo-1-phenylpyridine-3-carboxamide Chemical compound FC=1C=C(C=CC=1OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CNCCOC)NC(=O)C=1C(N(C=CC=1)C1=CC=CC=C1)=O WACIAMHZBIQEAD-UHFFFAOYSA-N 0.000 description 1
WBRANJSAHCFZMB-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-3-oxo-2-phenylpyridazine-4-carboxamide Chemical compound FC=1C=C(C=CC=1OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CNCCOC)NC(=O)C=1C(N(N=CC=1)C1=CC=CC=C1)=O WBRANJSAHCFZMB-UHFFFAOYSA-N 0.000 description 1
VRSPQJVMCVQUHO-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-4-methoxy-2-oxo-1-phenylpyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=C(F)C=C(NC(=O)C4=C(OC)C=CN(C4=O)C4=CC=CC=C4)C=C3)=C2S1 VRSPQJVMCVQUHO-UHFFFAOYSA-N 0.000 description 1
WAPQXVUOOSLPFI-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-4-methyl-2-oxo-1-phenylpyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=C(F)C=C(NC(=O)C4=C(C)C=CN(C4=O)C4=CC=CC=C4)C=C3)=C2S1 WAPQXVUOOSLPFI-UHFFFAOYSA-N 0.000 description 1
XNRNKJNBPKODHH-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-methyl-3-oxo-2-phenylpyridazine-4-carboxamide Chemical compound FC=1C=C(C=CC=1OC1=C2C(=NC=C1)C=C(S2)C1=NC=C(C=C1)CNCCOC)NC(=O)C=1C(N(N=CC=1C)C1=CC=CC=C1)=O XNRNKJNBPKODHH-UHFFFAOYSA-N 0.000 description 1
VQRCBMAZYVKSKI-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-6-methyl-2-oxo-1-phenylpyridine-3-carboxamide Chemical compound COCCNCC1=CN=C(C=C1)C1=CC2=NC=CC(OC3=C(F)C=C(NC(=O)C4=CC=C(C)N(C4=O)C4=CC=CC=C4)C=C3)=C2S1 VQRCBMAZYVKSKI-UHFFFAOYSA-N 0.000 description 1
UPUJVJGGGWMTSG-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-fluoroazetidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(C2)F)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 UPUJVJGGGWMTSG-UHFFFAOYSA-N 0.000 description 1
HXQIBWBUCIQLTI-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-fluoropyrrolidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical class FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(CC2)F)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 HXQIBWBUCIQLTI-UHFFFAOYSA-N 0.000 description 1
WJBMYQUYGJTCSS-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-hydroxy-3-methylazetidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(C2)(C)O)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 WJBMYQUYGJTCSS-UHFFFAOYSA-N 0.000 description 1
WQAMRVJISOUNEH-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-hydroxy-3-methylpyrrolidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(CC2)(C)O)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 WQAMRVJISOUNEH-UHFFFAOYSA-N 0.000 description 1
ADJPJHWSFRALOI-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-hydroxyazetidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(C2)O)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 ADJPJHWSFRALOI-UHFFFAOYSA-N 0.000 description 1
JJXKEKWCZWIABV-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-hydroxypiperidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical class FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(CCC2)O)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 JJXKEKWCZWIABV-UHFFFAOYSA-N 0.000 description 1
DBCOYBJDCMPKBZ-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-hydroxypyrrolidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical class FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(CC2)O)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 DBCOYBJDCMPKBZ-UHFFFAOYSA-N 0.000 description 1
OIPAVLJWOLFREU-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-methoxy-3-methylazetidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(C2)(C)OC)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 OIPAVLJWOLFREU-UHFFFAOYSA-N 0.000 description 1
KVKIPWDIMOOYNT-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-methoxyazetidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(C2)OC)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 KVKIPWDIMOOYNT-UHFFFAOYSA-N 0.000 description 1
GOZAMEQDBNUXEM-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-methoxypiperidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(CCC2)OC)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 GOZAMEQDBNUXEM-UHFFFAOYSA-N 0.000 description 1
JBUGZCUIASYMBG-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-methoxypyrrolidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(CC2)OC)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 JBUGZCUIASYMBG-UHFFFAOYSA-N 0.000 description 1
HOSBHAVSAZDEGX-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(3-methylazetidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(C2)C)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 HOSBHAVSAZDEGX-UHFFFAOYSA-N 0.000 description 1
JOIKLBWOIYENQT-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(4-fluoropiperidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical class FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CCC(CC2)F)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 JOIKLBWOIYENQT-UHFFFAOYSA-N 0.000 description 1
KPODPWSBFLRNPB-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(4-hydroxypiperidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical class FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CCC(CC2)O)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 KPODPWSBFLRNPB-UHFFFAOYSA-N 0.000 description 1
NUHYMEGFRWFIIX-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(4-methoxypiperidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CCC(CC2)OC)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 NUHYMEGFRWFIIX-UHFFFAOYSA-N 0.000 description 1
DACDNDAPULYOMV-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(4-methylpiperidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CCC(CC2)C)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 DACDNDAPULYOMV-UHFFFAOYSA-N 0.000 description 1
WNLPBEXHKZPYCH-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[(oxan-4-ylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CNC2CCOCC2)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 WNLPBEXHKZPYCH-UHFFFAOYSA-N 0.000 description 1
DIKGUEQZYWRARQ-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[[3-(hydroxymethyl)azetidin-1-yl]methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(C2)CO)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 DIKGUEQZYWRARQ-UHFFFAOYSA-N 0.000 description 1
ZUIBCRQFCGOTEZ-UHFFFAOYSA-N N-[3-fluoro-4-[2-[5-[[3-(methoxymethyl)azetidin-1-yl]methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=C2C(=NC=C1)C=C(S2)C2=NC=C(C=C2)CN2CC(C2)COC)NC(=O)C2=C1C(=CN(C2=O)C2=CC=C(C=C2)F)CCO1 ZUIBCRQFCGOTEZ-UHFFFAOYSA-N 0.000 description 1
NYPYIJMMLKPMED-UHFFFAOYSA-N N-[3-fluoro-4-[6-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC=C(C=C12)OCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 NYPYIJMMLKPMED-UHFFFAOYSA-N 0.000 description 1
OOVJNFUXCFAKFK-UHFFFAOYSA-N N-[3-fluoro-4-[6-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC=C(C=C12)OCCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 OOVJNFUXCFAKFK-UHFFFAOYSA-N 0.000 description 1
BDIQRAVIEUQAEF-UHFFFAOYSA-N N-[3-fluoro-4-[6-(methylcarbamoyl)-7-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)C(NC)=O)OCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 BDIQRAVIEUQAEF-UHFFFAOYSA-N 0.000 description 1
FXLZZISFEZCJAC-UHFFFAOYSA-N N-[3-fluoro-4-[6-(methylcarbamoyl)-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)C(NC)=O)OCCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 FXLZZISFEZCJAC-UHFFFAOYSA-N 0.000 description 1
OHKNBEPVBMLMKI-UHFFFAOYSA-N N-[3-fluoro-4-[6-fluoro-7-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)F)OCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 OHKNBEPVBMLMKI-UHFFFAOYSA-N 0.000 description 1
ZSJLRJLMABVNEH-UHFFFAOYSA-N N-[3-fluoro-4-[6-fluoro-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)F)OCCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 ZSJLRJLMABVNEH-UHFFFAOYSA-N 0.000 description 1
QMAWBKNMMCXHPG-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxyphenyl]-6-oxo-5-phenyl-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=CC=C1)CCO2 QMAWBKNMMCXHPG-UHFFFAOYSA-N 0.000 description 1
VRAPRBCISXLMRI-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-(2-morpholin-4-ylethylamino)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)NCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 VRAPRBCISXLMRI-UHFFFAOYSA-N 0.000 description 1
UIUYCXMOOSHYQK-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropanoylamino)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)NC(CCN1CCOCC1)=O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 UIUYCXMOOSHYQK-UHFFFAOYSA-N 0.000 description 1
XNSVBZCPDBOTBY-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-2-(4-fluorophenyl)-3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridine-4-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCC2 XNSVBZCPDBOTBY-UHFFFAOYSA-N 0.000 description 1
BVDXYSYVUNLAMR-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 BVDXYSYVUNLAMR-UHFFFAOYSA-N 0.000 description 1
RNFIQXJEDVMYST-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropylamino)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)NCCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 RNFIQXJEDVMYST-UHFFFAOYSA-N 0.000 description 1
DKMHYQGEPKUBCK-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 DKMHYQGEPKUBCK-UHFFFAOYSA-N 0.000 description 1
YHBKNHZCSWEQDS-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-(methylcarbamoyl)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)C(NC)=O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 YHBKNHZCSWEQDS-UHFFFAOYSA-N 0.000 description 1
PAFYSONZCTZPPZ-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[(2-morpholin-4-ylacetyl)amino]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)NC(CN1CCOCC1)=O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 PAFYSONZCTZPPZ-UHFFFAOYSA-N 0.000 description 1
IJHYKSVUNODUKO-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(3-methoxy-3-methylazetidin-1-yl)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(C1)(C)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 IJHYKSVUNODUKO-UHFFFAOYSA-N 0.000 description 1
XYHGZAHTXGGDOB-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(3-methoxyazetidin-1-yl)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(C1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 XYHGZAHTXGGDOB-UHFFFAOYSA-N 0.000 description 1
KJOGFQXSHXMCDQ-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(3-methoxypiperidin-1-yl)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(CCC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 KJOGFQXSHXMCDQ-UHFFFAOYSA-N 0.000 description 1
NCOPWIANAXVJLM-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(3-methoxypyrrolidin-1-yl)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(CC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 NCOPWIANAXVJLM-UHFFFAOYSA-N 0.000 description 1
IHAFGVPKZRYDMT-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(3-methylazetidin-1-yl)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(C1)C)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 IHAFGVPKZRYDMT-UHFFFAOYSA-N 0.000 description 1
WQCRYBSDPBSHPT-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(3-oxopiperidin-1-yl)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(CCC1)=O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 WQCRYBSDPBSHPT-UHFFFAOYSA-N 0.000 description 1
JVFKVZKXYXFNBM-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(4-methoxypiperidin-1-yl)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CCC(CC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 JVFKVZKXYXFNBM-UHFFFAOYSA-N 0.000 description 1
DPIKRPAIUDDALR-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(4-methylpiperidin-1-yl)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CCC(CC1)C)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 DPIKRPAIUDDALR-UHFFFAOYSA-N 0.000 description 1
PAIFMKMXBRNHFA-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(4-oxopiperidin-1-yl)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CCC(CC1)=O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 PAIFMKMXBRNHFA-UHFFFAOYSA-N 0.000 description 1
HWDVRGDVRUPWOR-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(oxan-4-ylamino)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCNC1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 HWDVRGDVRUPWOR-UHFFFAOYSA-N 0.000 description 1
JFCUAVAZIPZJRX-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(oxetan-3-ylamino)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCNC1COC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 JFCUAVAZIPZJRX-UHFFFAOYSA-N 0.000 description 1
GUPTYQLLEODFCM-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-(oxetan-3-ylmethylamino)ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCNCC1COC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 GUPTYQLLEODFCM-UHFFFAOYSA-N 0.000 description 1
AWTPLYANZZFXPK-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-[(3-methoxycyclobutyl)amino]ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCNC1CC(C1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 AWTPLYANZZFXPK-UHFFFAOYSA-N 0.000 description 1
AFLTYWRQKXGUTE-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-[(4-methoxycyclohexyl)amino]ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCNC1CCC(CC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 AFLTYWRQKXGUTE-UHFFFAOYSA-N 0.000 description 1
RLVPOGYPNWBLRM-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[2-[3-(methoxymethyl)azetidin-1-yl]ethoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(C1)COC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 RLVPOGYPNWBLRM-UHFFFAOYSA-N 0.000 description 1
DHSOQDHHNYARDQ-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(3-methoxy-3-methylazetidin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(C1)(C)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 DHSOQDHHNYARDQ-UHFFFAOYSA-N 0.000 description 1
UWPMFIOLLWNFFF-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(3-methoxyazetidin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(C1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 UWPMFIOLLWNFFF-UHFFFAOYSA-N 0.000 description 1
WPOBVEVUYDLPNR-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(3-methoxypiperidin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(CCC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 WPOBVEVUYDLPNR-UHFFFAOYSA-N 0.000 description 1
LROSTTMUVFHZDO-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(3-methoxypyrrolidin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(CC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 LROSTTMUVFHZDO-UHFFFAOYSA-N 0.000 description 1
JOMQSTVBHINKEB-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(3-methylazetidin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(C1)C)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 JOMQSTVBHINKEB-UHFFFAOYSA-N 0.000 description 1
FNAQAKMBQKOYPI-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCN(CC1)C)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 FNAQAKMBQKOYPI-UHFFFAOYSA-N 0.000 description 1
PURDNQRUAXESLZ-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(4-methylpiperidin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCC(CC1)C)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 PURDNQRUAXESLZ-UHFFFAOYSA-N 0.000 description 1
KKGIXMFZCSBGDU-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(4-oxopiperidin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCC(CC1)=O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 KKGIXMFZCSBGDU-UHFFFAOYSA-N 0.000 description 1
GRKUDBQNJPHGHG-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(oxan-4-ylamino)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCNC1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 GRKUDBQNJPHGHG-UHFFFAOYSA-N 0.000 description 1
MOEVQGWGBOEOES-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(oxan-4-ylmethylamino)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCNCC1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 MOEVQGWGBOEOES-UHFFFAOYSA-N 0.000 description 1
VKFFIKHWQNMBKO-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(oxetan-3-ylamino)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCNC1COC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 VKFFIKHWQNMBKO-UHFFFAOYSA-N 0.000 description 1
GIEMTOPNPSCEMW-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-(oxetan-3-ylmethylamino)propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCNCC1COC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 GIEMTOPNPSCEMW-UHFFFAOYSA-N 0.000 description 1
SWNQXEIHOLEASA-UHFFFAOYSA-N N-[3-fluoro-4-[6-methoxy-7-[3-[(3-methoxycyclobutyl)amino]propoxy]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCNC1CC(C1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 SWNQXEIHOLEASA-UHFFFAOYSA-N 0.000 description 1
RGADHYLIDXMOOB-UHFFFAOYSA-N N-[3-fluoro-4-[7-(2-morpholin-4-ylethoxy)-6-(trifluoromethyl)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)C(F)(F)F)OCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 RGADHYLIDXMOOB-UHFFFAOYSA-N 0.000 description 1
PYIMYYBWMFNMCV-UHFFFAOYSA-N N-[3-fluoro-4-[7-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=CC=C12)OCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 PYIMYYBWMFNMCV-UHFFFAOYSA-N 0.000 description 1
AZOVBBZKXMVYDO-UHFFFAOYSA-N N-[3-fluoro-4-[7-(3-morpholin-4-ylpropoxy)-6-(trifluoromethyl)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)C(F)(F)F)OCCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 AZOVBBZKXMVYDO-UHFFFAOYSA-N 0.000 description 1
SMDPADPLAXLSAK-UHFFFAOYSA-N N-[3-fluoro-4-[7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-2-(4-fluorophenyl)-3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridine-4-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=CC=C12)OCCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCC2 SMDPADPLAXLSAK-UHFFFAOYSA-N 0.000 description 1
SOIIEVULONKPPP-UHFFFAOYSA-N N-[3-fluoro-4-[7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=CC=C12)OCCCN1CCOCC1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 SOIIEVULONKPPP-UHFFFAOYSA-N 0.000 description 1
MITPLQJYUUQWNY-UHFFFAOYSA-N N-[3-fluoro-4-[7-(methylcarbamoyl)-6-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OCCN1CCOCC1)C(NC)=O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 MITPLQJYUUQWNY-UHFFFAOYSA-N 0.000 description 1
USASFKGRLVVWOT-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(3-fluoroazetidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(C1)F)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 USASFKGRLVVWOT-UHFFFAOYSA-N 0.000 description 1
VZKWAUPJRKPHQK-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(3-fluoropyrrolidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(CC1)F)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 VZKWAUPJRKPHQK-UHFFFAOYSA-N 0.000 description 1
WTZZGUVGJJAETM-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(3-hydroxy-3-methylazetidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(C1)(C)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 WTZZGUVGJJAETM-UHFFFAOYSA-N 0.000 description 1
LKAPWFSMUSTWEX-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(3-hydroxy-3-methylpyrrolidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(CC1)(C)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 LKAPWFSMUSTWEX-UHFFFAOYSA-N 0.000 description 1
QFAYERJNFKCECL-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(3-hydroxyazetidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(C1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 QFAYERJNFKCECL-UHFFFAOYSA-N 0.000 description 1
LXKOQQGKIABKHY-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(3-hydroxypiperidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(CCC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 LXKOQQGKIABKHY-UHFFFAOYSA-N 0.000 description 1
ZVUBMFMPLJOQBR-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(3-hydroxypyrrolidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(CC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 ZVUBMFMPLJOQBR-UHFFFAOYSA-N 0.000 description 1
BKOVOQGMKYZRQJ-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(4-fluoropiperidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CCC(CC1)F)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 BKOVOQGMKYZRQJ-UHFFFAOYSA-N 0.000 description 1
XGIOGJFVEXVKBS-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(4-hydroxy-4-methylpiperidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CCC(CC1)(C)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 XGIOGJFVEXVKBS-UHFFFAOYSA-N 0.000 description 1
OMQCCWPHMNNCNV-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-(4-hydroxypiperidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CCC(CC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 OMQCCWPHMNNCNV-UHFFFAOYSA-N 0.000 description 1
BFKXRABXTYICCX-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-[(3-hydroxycyclobutyl)amino]ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCNC1CC(C1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 BFKXRABXTYICCX-UHFFFAOYSA-N 0.000 description 1
LODRQXGHYZIMFO-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-[(3-hydroxycyclohexyl)amino]ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCNC1CC(CCC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 LODRQXGHYZIMFO-UHFFFAOYSA-N 0.000 description 1
BOFPUSKJEDDIGG-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-[(3-hydroxycyclohexyl)methylamino]ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCNCC1CC(CCC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 BOFPUSKJEDDIGG-UHFFFAOYSA-N 0.000 description 1
VUMXHTIJDPOGPU-UHFFFAOYSA-N N-[3-fluoro-4-[7-[2-[3-(hydroxymethyl)azetidin-1-yl]ethoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCN1CC(C1)CO)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 VUMXHTIJDPOGPU-UHFFFAOYSA-N 0.000 description 1
WWENPRBJJSOZEL-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(3-fluoroazetidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(C1)F)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 WWENPRBJJSOZEL-UHFFFAOYSA-N 0.000 description 1
JPWUEGVBYANVOD-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(3-fluoropyrrolidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(CC1)F)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 JPWUEGVBYANVOD-UHFFFAOYSA-N 0.000 description 1
VXBCLVGGQRSXIF-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(3-hydroxy-3-methylazetidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(C1)(C)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 VXBCLVGGQRSXIF-UHFFFAOYSA-N 0.000 description 1
KGPRVECCTKCEFY-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(3-hydroxy-3-methylpyrrolidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(CC1)(C)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 KGPRVECCTKCEFY-UHFFFAOYSA-N 0.000 description 1
REMOWWZSHHMLOU-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(3-hydroxyazetidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(C1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 REMOWWZSHHMLOU-UHFFFAOYSA-N 0.000 description 1
DRDZFQJQQVZNEQ-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(3-hydroxypiperidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(CCC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 DRDZFQJQQVZNEQ-UHFFFAOYSA-N 0.000 description 1
KFHAWJJMPGILRL-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(3-hydroxypyrrolidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(CC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 KFHAWJJMPGILRL-UHFFFAOYSA-N 0.000 description 1
PUVHHPINXSPAPE-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(4-fluoropiperidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCC(CC1)F)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 PUVHHPINXSPAPE-UHFFFAOYSA-N 0.000 description 1
QXBHWGRLVHYMPN-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(4-hydroxy-4-methylpiperidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCC(CC1)(C)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 QXBHWGRLVHYMPN-UHFFFAOYSA-N 0.000 description 1
CZOQUQAOSGEPLS-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-(4-hydroxypiperidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCC(CC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 CZOQUQAOSGEPLS-UHFFFAOYSA-N 0.000 description 1
LUENBHVXZMMXHA-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-[(3-hydroxycyclobutyl)amino]propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCNC1CC(C1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 LUENBHVXZMMXHA-UHFFFAOYSA-N 0.000 description 1
NFAQVECZNACUMF-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-[(3-hydroxycyclohexyl)amino]propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCNC1CC(CCC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 NFAQVECZNACUMF-UHFFFAOYSA-N 0.000 description 1
YYRSNJKXDGAZJV-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-[(3-hydroxycyclohexyl)methylamino]propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCNCC1CC(CCC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 YYRSNJKXDGAZJV-UHFFFAOYSA-N 0.000 description 1
GBIALMONTLCCCN-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-[(3-hydroxycyclopentyl)amino]propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCNC1CC(CC1)O)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 GBIALMONTLCCCN-UHFFFAOYSA-N 0.000 description 1
LAVCFIIBDBMDMK-UHFFFAOYSA-N N-[3-fluoro-4-[7-[3-[3-(hydroxymethyl)azetidin-1-yl]propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CC(C1)CO)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 LAVCFIIBDBMDMK-UHFFFAOYSA-N 0.000 description 1
NPJAIIATRRDFLT-UHFFFAOYSA-N N-[3-fluoro-4-[7-methoxy-6-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OCCN1CCOCC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 NPJAIIATRRDFLT-UHFFFAOYSA-N 0.000 description 1
BLNONYNHOWYRMW-UHFFFAOYSA-N N-[3-fluoro-4-[7-methoxy-6-(2-morpholin-4-ylethylamino)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)NCCN1CCOCC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 BLNONYNHOWYRMW-UHFFFAOYSA-N 0.000 description 1
XAOOKGFWRQJMJL-UHFFFAOYSA-N N-[3-fluoro-4-[7-methoxy-6-(2-morpholin-4-ylethylcarbamoyl)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)C(NCCN1CCOCC1)=O)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 XAOOKGFWRQJMJL-UHFFFAOYSA-N 0.000 description 1
OQLZIMNKPPLZLH-UHFFFAOYSA-N N-[3-fluoro-4-[7-methoxy-6-(3-morpholin-4-ylpropanoylamino)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)NC(CCN1CCOCC1)=O)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 OQLZIMNKPPLZLH-UHFFFAOYSA-N 0.000 description 1
XQPUOXJYDTYZQD-UHFFFAOYSA-N N-[3-fluoro-4-[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OCCCN1CCOCC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 XQPUOXJYDTYZQD-UHFFFAOYSA-N 0.000 description 1
BRGBBFQPPTZZHA-UHFFFAOYSA-N N-[3-fluoro-4-[7-methoxy-6-(3-morpholin-4-ylpropylamino)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)NCCCN1CCOCC1)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 BRGBBFQPPTZZHA-UHFFFAOYSA-N 0.000 description 1
BLZQZOOSLNXNRP-UHFFFAOYSA-N N-[3-fluoro-4-[7-methoxy-6-(methylcarbamoyl)quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)C(NC)=O)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 BLZQZOOSLNXNRP-UHFFFAOYSA-N 0.000 description 1
DLXDYJKSTYIMMR-UHFFFAOYSA-N N-[3-fluoro-4-[7-methoxy-6-[(2-morpholin-4-ylacetyl)amino]quinolin-4-yl]oxyphenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)NC(CN1CCOCC1)=O)OC)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2 DLXDYJKSTYIMMR-UHFFFAOYSA-N 0.000 description 1
VJZRIGQJTMZPJD-UHFFFAOYSA-N N-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound COC=1C=C2C(=NC=NC2=CC1OC)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F VJZRIGQJTMZPJD-UHFFFAOYSA-N 0.000 description 1
UWACFQPBGHPCEV-UHFFFAOYSA-N N-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-5-(3-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC(=CC=C1)F)CCO2)F UWACFQPBGHPCEV-UHFFFAOYSA-N 0.000 description 1
TVYSGPQRXKEAIJ-UHFFFAOYSA-N N-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F TVYSGPQRXKEAIJ-UHFFFAOYSA-N 0.000 description 1
YNCWRFVWOXMFDT-UHFFFAOYSA-N N-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-6-oxo-5-[4-(trifluoromethyl)phenyl]-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)C(F)(F)F)CCO2)F YNCWRFVWOXMFDT-UHFFFAOYSA-N 0.000 description 1
TZWPLVLWMGBSIH-UHFFFAOYSA-N N-[4-(6-acetamido-7-methoxyquinolin-4-yl)oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound C(C)(=O)NC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F TZWPLVLWMGBSIH-UHFFFAOYSA-N 0.000 description 1
FCRWKQOYLIBJDD-UHFFFAOYSA-N N-[4-(6-amino-7-methoxyquinolin-4-yl)oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound NC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F FCRWKQOYLIBJDD-UHFFFAOYSA-N 0.000 description 1
XHDYPDKUVYPXMW-UHFFFAOYSA-N N-[4-(6-carbamoyl-7-methoxyquinolin-4-yl)oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound C(N)(=O)C=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F XHDYPDKUVYPXMW-UHFFFAOYSA-N 0.000 description 1
XDFIDWCEXITKGW-UHFFFAOYSA-N N-[4-(7-acetamido-6-methoxyquinolin-4-yl)oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound C(C)(=O)NC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC XDFIDWCEXITKGW-UHFFFAOYSA-N 0.000 description 1
IPPIWPSGBBLRBV-UHFFFAOYSA-N N-[4-(7-amino-6-methoxyquinolin-4-yl)oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound NC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC IPPIWPSGBBLRBV-UHFFFAOYSA-N 0.000 description 1
VNBRGSXVFBYQNN-UHFFFAOYSA-N N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-3-pyridinecarboxamide Chemical compound O=C1C(C(=O)NC=2C=C(F)C(OC=3C(=C(N)N=CC=3)Cl)=CC=2)=C(OCC)C=CN1C1=CC=C(F)C=C1 VNBRGSXVFBYQNN-UHFFFAOYSA-N 0.000 description 1
LZPGJYGOHCBIIA-UHFFFAOYSA-N N-[4-[2-[5-[(3,3-difluoroazetidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC1(CN(C1)CC=1C=CC(=NC1)C1=CC2=NC=CC(=C2S1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)F LZPGJYGOHCBIIA-UHFFFAOYSA-N 0.000 description 1
TUBRBXLFVYJGTC-UHFFFAOYSA-N N-[4-[2-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC1(CN(CC1)CC=1C=CC(=NC1)C1=CC2=NC=CC(=C2S1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)F TUBRBXLFVYJGTC-UHFFFAOYSA-N 0.000 description 1
INNNLNWGFYFAJI-UHFFFAOYSA-N N-[4-[2-[5-[(3,3-dimethylazetidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical class CC1(CN(C1)CC=1C=CC(=NC1)C1=CC2=NC=CC(=C2S1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)C INNNLNWGFYFAJI-UHFFFAOYSA-N 0.000 description 1
IBFOOZCHODHVNQ-UHFFFAOYSA-N N-[4-[2-[5-[(3-cyanoazetidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound C(#N)C1CN(C1)CC=1C=CC(=NC1)C1=CC2=NC=CC(=C2S1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F IBFOOZCHODHVNQ-UHFFFAOYSA-N 0.000 description 1
JURGXRDVJKUGKH-UHFFFAOYSA-N N-[4-[2-[5-[(4,4-difluoropiperidin-1-yl)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC1(CCN(CC1)CC=1C=CC(=NC1)C1=CC2=NC=CC(=C2S1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)F JURGXRDVJKUGKH-UHFFFAOYSA-N 0.000 description 1
YRPGOEPISCCVBC-UHFFFAOYSA-N N-[4-[6-(dimethylcarbamoyl)-7-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound CN(C(=O)C=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)C YRPGOEPISCCVBC-UHFFFAOYSA-N 0.000 description 1
OKFJJQVLGMMRFA-UHFFFAOYSA-N N-[4-[6-(ethylcarbamoyl)-7-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound C(C)NC(=O)C=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F OKFJJQVLGMMRFA-UHFFFAOYSA-N 0.000 description 1
MGFSCLBHAVDYTG-UHFFFAOYSA-N N-[4-[6-cyano-7-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound C(#N)C=1C=C2C(=CC=NC2=CC1OCCN1CCOCC1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F MGFSCLBHAVDYTG-UHFFFAOYSA-N 0.000 description 1
GCBWJVARYRNJPT-UHFFFAOYSA-N N-[4-[6-cyano-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound C(#N)C=1C=C2C(=CC=NC2=CC1OCCCN1CCOCC1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F GCBWJVARYRNJPT-UHFFFAOYSA-N 0.000 description 1
DMECAKLIFWHZCZ-UHFFFAOYSA-N N-[4-[7-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound O=S1(CCN(CC1)CCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC)=O DMECAKLIFWHZCZ-UHFFFAOYSA-N 0.000 description 1
JSDIXYRCEGLKRJ-UHFFFAOYSA-N N-[4-[7-[2-(3,3-difluoroazetidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC1(CN(C1)CCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC)F JSDIXYRCEGLKRJ-UHFFFAOYSA-N 0.000 description 1
IEIWEMYMDPEGAX-UHFFFAOYSA-N N-[4-[7-[2-(3,3-dimethylazetidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound CC1(CN(C1)CCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC)C IEIWEMYMDPEGAX-UHFFFAOYSA-N 0.000 description 1
KXIOLHLUYJOKKQ-UHFFFAOYSA-N N-[4-[7-[2-(3-ethynylazetidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound C(#C)C1CN(C1)CCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC KXIOLHLUYJOKKQ-UHFFFAOYSA-N 0.000 description 1
HEZCEZVRZPNGQM-UHFFFAOYSA-N N-[4-[7-[2-(4,4-dimethylpiperidin-1-yl)ethoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound CC1(CCN(CC1)CCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC)C HEZCEZVRZPNGQM-UHFFFAOYSA-N 0.000 description 1
STKZOWGQTWVVEX-UHFFFAOYSA-N N-[4-[7-[2-[3-(dimethylamino)azetidin-1-yl]ethoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound CN(C1CN(C1)CCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC)C STKZOWGQTWVVEX-UHFFFAOYSA-N 0.000 description 1
HKINPIICPBWEFZ-UHFFFAOYSA-N N-[4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)propoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound O=S1(CCN(CC1)CCCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC)=O HKINPIICPBWEFZ-UHFFFAOYSA-N 0.000 description 1
BKPCVIXGDOGZIV-UHFFFAOYSA-N N-[4-[7-[3-(3,3-difluoroazetidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound FC1(CN(C1)CCCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC)F BKPCVIXGDOGZIV-UHFFFAOYSA-N 0.000 description 1
XBOLVYJXHVXKMC-UHFFFAOYSA-N N-[4-[7-[3-(4,4-dimethylpiperidin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-5-(4-fluorophenyl)-6-oxo-2,3-dihydrofuro[3,2-c]pyridine-7-carboxamide Chemical compound CC1(CCN(CC1)CCCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)NC(=O)C1=C2C(=CN(C1=O)C1=CC=C(C=C1)F)CCO2)F)OC)C XBOLVYJXHVXKMC-UHFFFAOYSA-N 0.000 description 1
ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
108010079364 N-glycylalanine Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
229930012538 Paclitaxel Natural products 0.000 description 1
241001494479 Pecora Species 0.000 description 1
MPFGIYLYWUCSJG-AVGNSLFASA-N Phe-Glu-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MPFGIYLYWUCSJG-AVGNSLFASA-N 0.000 description 1
KRYSMKKRRRWOCZ-QEWYBTABSA-N Phe-Ile-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KRYSMKKRRRWOCZ-QEWYBTABSA-N 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
229940079156 Proteasome inhibitor Drugs 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
239000012979 RPMI medium Substances 0.000 description 1
108091005682 Receptor kinases Proteins 0.000 description 1
229940127395 Ribonucleotide Reductase Inhibitors Drugs 0.000 description 1
HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 1
WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 1
IYCBDVBJWDXQRR-FXQIFTODSA-N Ser-Ala-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IYCBDVBJWDXQRR-FXQIFTODSA-N 0.000 description 1
OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 1
HJEBZBMOTCQYDN-ACZMJKKPSA-N Ser-Glu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HJEBZBMOTCQYDN-ACZMJKKPSA-N 0.000 description 1
FGBLCMLXHRPVOF-IHRRRGAJSA-N Ser-Tyr-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FGBLCMLXHRPVOF-IHRRRGAJSA-N 0.000 description 1
ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
241000282887 Suidae Species 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
244000299461 Theobroma cacao Species 0.000 description 1
235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 1
TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 1
LHUBVKCLOVALIA-HJGDQZAQSA-N Thr-Arg-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O LHUBVKCLOVALIA-HJGDQZAQSA-N 0.000 description 1
AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 1
ZBKDBZUTTXINIX-RWRJDSDZSA-N Thr-Ile-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZBKDBZUTTXINIX-RWRJDSDZSA-N 0.000 description 1
XSEPSRUDSPHMPX-KATARQTJSA-N Thr-Lys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XSEPSRUDSPHMPX-KATARQTJSA-N 0.000 description 1
MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 1
101710183280 Topoisomerase Proteins 0.000 description 1
239000000365 Topoisomerase I Inhibitor Substances 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
206010064390 Tumour invasion Diseases 0.000 description 1
FMXFHNSFABRVFZ-BZSNNMDCSA-N Tyr-Lys-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O FMXFHNSFABRVFZ-BZSNNMDCSA-N 0.000 description 1
BBSPTGPYIPGTKH-JYJNAYRXSA-N Tyr-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N BBSPTGPYIPGTKH-JYJNAYRXSA-N 0.000 description 1
PWKMJDQXKCENMF-MEYUZBJRSA-N Tyr-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O PWKMJDQXKCENMF-MEYUZBJRSA-N 0.000 description 1
VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 1
OVLIFGQSBSNGHY-KKHAAJSZSA-N Val-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N)O OVLIFGQSBSNGHY-KKHAAJSZSA-N 0.000 description 1
SYOMXKPPFZRELL-ONGXEEELSA-N Val-Gly-Lys Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N SYOMXKPPFZRELL-ONGXEEELSA-N 0.000 description 1
LKUDRJSNRWVGMS-QSFUFRPTSA-N Val-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LKUDRJSNRWVGMS-QSFUFRPTSA-N 0.000 description 1
KTEZUXISLQTDDQ-NHCYSSNCSA-N Val-Lys-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KTEZUXISLQTDDQ-NHCYSSNCSA-N 0.000 description 1
LJSZPMSUYKKKCP-UBHSHLNASA-N Val-Phe-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 LJSZPMSUYKKKCP-UBHSHLNASA-N 0.000 description 1
WANVRBAZGSICCP-SRVKXCTJSA-N Val-Pro-Met Chemical compound CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(O)=O WANVRBAZGSICCP-SRVKXCTJSA-N 0.000 description 1
AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 1
JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
230000004913 activation Effects 0.000 description 1
101150063416 add gene Proteins 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
238000009098 adjuvant therapy Methods 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
239000000556 agonist Substances 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
229930013930 alkaloid Natural products 0.000 description 1
230000002152 alkylating effect Effects 0.000 description 1
HZVVJJIYJKGMFL-UHFFFAOYSA-N almasilate Chemical compound O.[Mg+2].[Al+3].[Al+3].O[Si](O)=O.O[Si](O)=O HZVVJJIYJKGMFL-UHFFFAOYSA-N 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000002280 anti-androgenic effect Effects 0.000 description 1
230000001772 anti-angiogenic effect Effects 0.000 description 1
229940046836 anti-estrogen Drugs 0.000 description 1
230000001833 anti-estrogenic effect Effects 0.000 description 1
230000000719 anti-leukaemic effect Effects 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
230000000118 anti-neoplastic effect Effects 0.000 description 1
239000000051 antiandrogen Substances 0.000 description 1
229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
229940034982 antineoplastic agent Drugs 0.000 description 1
229940045985 antineoplastic platinum compound Drugs 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
108010062796 arginyllysine Proteins 0.000 description 1
239000003886 aromatase inhibitor Substances 0.000 description 1
229940046844 aromatase inhibitors Drugs 0.000 description 1
108010047857 aspartylglycine Proteins 0.000 description 1
238000003556 assay Methods 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
125000003725 azepanyl group Chemical group 0.000 description 1
HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
125000004069 aziridinyl group Chemical group 0.000 description 1
230000008901 benefit Effects 0.000 description 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
238000001815 biotherapy Methods 0.000 description 1
QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
150000004663 bisphosphonates Chemical class 0.000 description 1
229960001561 bleomycin Drugs 0.000 description 1
OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
238000010322 bone marrow transplantation Methods 0.000 description 1
229960002092 busulfan Drugs 0.000 description 1
235000014121 butter Nutrition 0.000 description 1
ONIQOQHATWINJY-UHFFFAOYSA-N cabozantinib Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)C1(C(=O)NC=2C=CC(F)=CC=2)CC1 ONIQOQHATWINJY-UHFFFAOYSA-N 0.000 description 1
229960001292 cabozantinib Drugs 0.000 description 1
235000001046 cacaotero Nutrition 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
239000000378 calcium silicate Substances 0.000 description 1
229910052918 calcium silicate Inorganic materials 0.000 description 1
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
239000008116 calcium stearate Substances 0.000 description 1
235000013539 calcium stearate Nutrition 0.000 description 1
OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
230000009400 cancer invasion Effects 0.000 description 1
229960004117 capecitabine Drugs 0.000 description 1
125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
150000001721 carbon Chemical group 0.000 description 1
239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
229960005243 carmustine Drugs 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000011748 cell maturation Effects 0.000 description 1
230000005754 cellular signaling Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000002113 chemopreventative effect Effects 0.000 description 1
230000000973 chemotherapeutic effect Effects 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
229960004630 chlorambucil Drugs 0.000 description 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
229960004316 cisplatin Drugs 0.000 description 1
238000010835 comparative analysis Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
KTEIFNKAUNYNJU-GFCCVEGCSA-N crizotinib Chemical compound O([C@H](C)C=1C(=C(F)C=CC=1Cl)Cl)C(C(=NC=1)N)=CC=1C(=C1)C=NN1C1CCNCC1 KTEIFNKAUNYNJU-GFCCVEGCSA-N 0.000 description 1
229960005061 crizotinib Drugs 0.000 description 1
238000012258 culturing Methods 0.000 description 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
229960004397 cyclophosphamide Drugs 0.000 description 1
FEHLGOYZDFFMND-UHFFFAOYSA-N cyclopropane-1,1-dicarboxamide Chemical compound NC(=O)C1(C(N)=O)CC1 FEHLGOYZDFFMND-UHFFFAOYSA-N 0.000 description 1
229960000975 daunorubicin Drugs 0.000 description 1
STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
239000003954 decarboxylase inhibitor Substances 0.000 description 1
125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
230000001934 delay Effects 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
QPMLSUSACCOBDK-UHFFFAOYSA-N diazepane Chemical compound C1CCNNCC1 QPMLSUSACCOBDK-UHFFFAOYSA-N 0.000 description 1
125000005959 diazepanyl group Chemical group 0.000 description 1
125000005331 diazinyl group Chemical group N1=NC(=CC=C1)* 0.000 description 1
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
101150042537 dld1 gene Proteins 0.000 description 1
229960003668 docetaxel Drugs 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
230000000235 effect on cancer Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000000328 estrogen antagonist Substances 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
229960005420 etoposide Drugs 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
JYEFSHLLTQIXIO-SMNQTINBSA-N folfiri regimen Chemical compound FC1=CNC(=O)NC1=O.C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 JYEFSHLLTQIXIO-SMNQTINBSA-N 0.000 description 1
239000011672 folinic acid Substances 0.000 description 1
VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 1
235000008191 folinic acid Nutrition 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 1
VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
108010078326 glycyl-glycyl-valine Proteins 0.000 description 1
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
229960001442 gonadorelin Drugs 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000003862 health status Effects 0.000 description 1
239000003481 heat shock protein 90 inhibitor Substances 0.000 description 1
230000002439 hemostatic effect Effects 0.000 description 1
108010037536 heparanase Proteins 0.000 description 1
125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000003037 histogenic effect Effects 0.000 description 1
229940121372 histone deacetylase inhibitor Drugs 0.000 description 1
239000003276 histone deacetylase inhibitor Substances 0.000 description 1
238000001794 hormone therapy Methods 0.000 description 1
102000056097 human CTNNB1 Human genes 0.000 description 1
125000001183 hydrocarbyl group Chemical group 0.000 description 1
229960000908 idarubicin Drugs 0.000 description 1
229960001101 ifosfamide Drugs 0.000 description 1
HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 1
125000002632 imidazolidinyl group Chemical group 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
239000000367 immunologic factor Substances 0.000 description 1
238000012744 immunostaining Methods 0.000 description 1
238000009169 immunotherapy Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
125000001041 indolyl group Chemical group 0.000 description 1
230000006698 induction Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
229960004768 irinotecan Drugs 0.000 description 1
UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 1
125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
125000005956 isoquinolyl group Chemical group 0.000 description 1
125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
125000003965 isoxazolidinyl group Chemical group 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
108010053037 kyotorphin Proteins 0.000 description 1
VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
229960001691 leucovorin Drugs 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
229960002247 lomustine Drugs 0.000 description 1
238000011866 long-term treatment Methods 0.000 description 1
229940124302 mTOR inhibitor Drugs 0.000 description 1
229960003511 macrogol Drugs 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
102000049853 macrophage stimulating protein Human genes 0.000 description 1
108010053292 macrophage stimulating protein Proteins 0.000 description 1
239000003628 mammalian target of rapamycin inhibitor Substances 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
229960002900 methylcellulose Drugs 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
210000004688 microtubule Anatomy 0.000 description 1
CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 1
239000002829 mitogen activated protein kinase inhibitor Substances 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
229960001156 mitoxantrone Drugs 0.000 description 1
KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
125000002950 monocyclic group Chemical group 0.000 description 1
235000010460 mustard Nutrition 0.000 description 1
229960003966 nicotinamide Drugs 0.000 description 1
239000011570 nicotinamide Substances 0.000 description 1
239000012457 nonaqueous media Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
125000003566 oxetanyl group Chemical group 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
125000004430 oxygen atom Chemical group O* 0.000 description 1
229960001592 paclitaxel Drugs 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
230000037361 pathway Effects 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
230000002165 photosensitisation Effects 0.000 description 1
239000003504 photosensitizing agent Chemical class 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
150000003058 platinum compounds Chemical class 0.000 description 1
229960003171 plicamycin Drugs 0.000 description 1
125000003367 polycyclic group Chemical group 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000002599 prostaglandin synthase inhibitor Substances 0.000 description 1
239000003207 proteasome inhibitor Substances 0.000 description 1
229940121649 protein inhibitor Drugs 0.000 description 1
239000012268 protein inhibitor Substances 0.000 description 1
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
125000003072 pyrazolidinyl group Chemical group 0.000 description 1
125000005412 pyrazyl group Chemical group 0.000 description 1
125000005495 pyridazyl group Chemical group 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
125000005493 quinolyl group Chemical group 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
108010014186 ras Proteins Proteins 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000009256 replacement therapy Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
102220014333 rs112445441 Human genes 0.000 description 1
102200006538 rs121913530 Human genes 0.000 description 1
102200006533 rs121913535 Human genes 0.000 description 1
229930195734 saturated hydrocarbon Natural products 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
229960001052 streptozocin Drugs 0.000 description 1
ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000011477 surgical intervention Methods 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000002626 targeted therapy Methods 0.000 description 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
239000003277 telomerase inhibitor Substances 0.000 description 1
NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 1
229960001278 teniposide Drugs 0.000 description 1
WYTGPUFDTMRMGN-UHFFFAOYSA-N tert-butyl N-[[6-[7-[4-[[4-ethoxy-1-(4-fluorophenyl)-2-oxopyridine-3-carbonyl]amino]-2-fluorophenoxy]thieno[3,2-b]pyridin-2-yl]pyridin-3-yl]methyl]-N-(2-methoxyethyl)carbamate Chemical compound C(C)OC1=C(C(N(C=C1)C1=CC=C(C=C1)F)=O)C(=O)NC1=CC(=C(OC2=C3C(=NC=C2)C=C(S3)C2=CC=C(C=N2)CN(C(OC(C)(C)C)=O)CCOC)C=C1)F WYTGPUFDTMRMGN-UHFFFAOYSA-N 0.000 description 1
125000001984 thiazolidinyl group Chemical group 0.000 description 1
125000001544 thienyl group Chemical group 0.000 description 1
229960001196 thiotepa Drugs 0.000 description 1
229960000303 topotecan Drugs 0.000 description 1
UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 description 1
238000001890 transfection Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
230000005748 tumor development Effects 0.000 description 1
230000005751 tumor progression Effects 0.000 description 1
231100000588 tumorigenic Toxicity 0.000 description 1
230000000381 tumorigenic effect Effects 0.000 description 1
125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000008371 vanilla flavor Substances 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
229960003048 vinblastine Drugs 0.000 description 1
JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
229960004528 vincristine Drugs 0.000 description 1
OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1